S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Did You Get Your Free Bitcoin Yet? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Options trading has suddenly become more reliable. (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Did You Get Your Free Bitcoin Yet? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Options trading has suddenly become more reliable. (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Did You Get Your Free Bitcoin Yet? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Options trading has suddenly become more reliable. (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Did You Get Your Free Bitcoin Yet? (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Options trading has suddenly become more reliable. (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
[Urgent!] Generational Wealth Gameplan (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Free Trial
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)
Free MRMD Stock Alerts
$0.27
0.00 (0.00%)
(As of 04/17/2024 ET)
Compare
Today's Range
$0.26
▼
$0.28
50-Day Range
$0.20
▼
$0.33
52-Week Range
$0.20
▼
$0.55
Volume
78,252 shs
Average Volume
485,535 shs
Market Capitalization
$100.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest
MRMD stock logo

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

MRMD Stock News Headlines

April 17, 2024 | benzinga.com
'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy
April 16, 2024 | americanbankingnews.com
Critical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)
April 17, 2024 | Wall Street Star (Ad)
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
April 13, 2024 | uk.investing.com
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary
April 11, 2024 | msn.com
MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary
April 11, 2024 | finance.yahoo.com
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
April 11, 2024 | finance.yahoo.com
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary
April 11, 2024 | globenewswire.com
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary
April 17, 2024 | Wall Street Star (Ad)
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
April 10, 2024 | bizjournals.com
Mass. cannabis firm sponsors MGM Music Hall, House of Blues
April 10, 2024 | globenewswire.com
MariMed Partners with Iconic Boston Music Venues
April 10, 2024 | globenewswire.com
MariMed Partners with Iconic Boston Music Venues
April 9, 2024 | finanznachrichten.de
MariMed Inc.: MariMed Closes Acquisition of Second Maryland Dispensary
April 9, 2024 | globenewswire.com
MariMed Closes Acquisition of Second Maryland Dispensary
April 8, 2024 | globenewswire.com
MariMed Announces First Quarter 2024 Earnings Date
March 27, 2024 | msn.com
'Unsexy' Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-Sustainable
March 12, 2024 | globenewswire.com
A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois
March 9, 2024 | seekingalpha.com
MariMed Inc. (MRMD) Q4 2023 Earnings Call Transcript
March 8, 2024 | finance.yahoo.com
MariMed Inc. (PNK:MRMD) Q4 2023 Earnings Call Transcript
March 8, 2024 | finanznachrichten.de
MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2023 Earnings
March 7, 2024 | msn.com
MariMed Reports 'Another Year Of Strong Operational And Financial Performance' And More To Come In 2024
March 7, 2024 | investorplace.com
MRMD Stock Earnings: MariMed Beats Revenue for Q4 2023
March 6, 2024 | benzinga.com
MariMed's Earnings: A Preview
March 6, 2024 | globenewswire.com
MariMed Reports Fourth Quarter and Full Year 2023 Earnings
March 4, 2024 | finance.yahoo.com
MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep
March 4, 2024 | globenewswire.com
MariMed's Betty's Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night's Sleep
March 4, 2024 | globenewswire.com
MariMed's Betty's Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night's Sleep
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/17/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRMD
CUSIP
N/A
CIK
1522767
Web
marimedadvisors.com
Phone
(617) 795-5140
Fax
N/A
Employees
643
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,030,000.00
Net Margins
-10.79%
Pretax Margin
-4.44%
Return on Equity
-1.84%
Return on Assets
-0.72%

Debt

Debt-to-Equity Ratio
0.97
Current Ratio
1.67
Quick Ratio
0.85

Sales & Book Value

Annual Sales
$148.60 million
Price / Sales
0.68
Cash Flow
$0.03 per share
Price / Cash Flow
9.05
Book Value
$0.19 per share
Price / Book
1.42

Miscellaneous

Outstanding Shares
375,130,000
Free Float
298,041,000
Market Cap
$100.91 million
Optionable
Not Optionable
Beta
2.85
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jon R. Levine (Age 59)
    Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
    Comp: $481.74k
  • Mr. Timothy Shaw (Age 46)
    Chief Operating Officer
    Comp: $445.86k
  • Mr. Jonathan W. Rider (Age 59)
    Chief Information Officer
  • Mr. Steve Wayne West
    Vice President of Investor Relations
  • Mr. Howard Schacter
    Chief Communications Officer
  • Ms. Sara Gullickson (Age 39)
    Vice President of Marketing
  • Mr. Ryan Crandall
    Chief Revenue Officer
  • Mr. Charles Holt Finnie
    Chief Strategy Officer

Key Competitors

View All Competitors

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the beginning of 2024. Since then, MRMD stock has decreased by 2.1% and is now trading at $0.2690.
View the best growth stocks for 2024 here.

Are investors shorting MariMed?

MariMed saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 34,400 shares, a decrease of 35.3% from the March 15th total of 53,200 shares. Based on an average daily trading volume, of 1,116,200 shares, the short-interest ratio is presently 0.0 days.
View MariMed's Short Interest.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings data on Monday, November, 15th. The company reported $0.01 EPS for the quarter. The company earned $33.21 million during the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%.

What guidance has MariMed issued on next quarter's earnings?

MariMed updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA).

How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
AI healthcare stock poised for 36,996% growth?
Behind the Markets
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
New Trump Bombshell
The Freeport Society